-
MyChart
Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
-
Request an Appointment
Request an Appointment
If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment Information - Donate Today
Study #ALLIANCEA221208
RANDOMIZED PHASE II STUDY: CORTICOSTEROIDS + BEVACIZUMAB VS. CORTICOSTEROIDS + PLACEBO (BEST) FOR RADIONECROSIS AFTER RADIOSURGERY FOR BRAIN METASTASES
Study Status
Open
Treatment Agent
Bevacizumab,Corticosteroid
Principal Investigator
Barbara J. O'Brien
Description
Unavailable
General Information
Disease Group: Diseases of the nervous system
Treatment Agent: Bevacizumab,Corticosteroid
Treatment Location: Both at MDACC & and Other Sites
Sponsor: NCI National Clinical Trial Network (NCTN)/Alliance
Study Status
IRB Review and Approval Date: 02/22/2017
Recruitment Status: Open
Projected Accrual: 130
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Diseases of the nervous system
Study phase:
Phase II
Physician name:
Barbara J. O'Brien
Department:
Neuro Oncology
For general questions about clinical trials:
1-877-632-6789